Dr. Sanjay Gupta, the chief medical correspondent for CNN, has been exploring the effects of smoking cannabis for a couple of years now. He believes that cannabis provides considerable medical benefits. His most recent report, which focused on the use of cannabis to help relieve pain and symptoms of various health conditions, discusses his thoughts on the matter.
During his quest to learn more about marijuana’s benefits, Gupta discovered a study conducted in Israel by a world renowned scientist, Raphael Mechoulam. The study centered on the use of cannabis as a treatment for refractory seizures in children. While additional studies are needed to learn more about the mechanisms behind how cannabis works, the researcher observed a reduction in seizures, especially in children who didn’t respond to existing seizure medication.
Mechoulam believes that major advances in the treatment and medical-scientific aspects of epilepsy with the help of cannabinoids such as CBD will soon be realized. This comes after the U.S. FDA approved an oral CBD solution known as Epidiolex for the treatment of seizures linked to Dravet syndrome and Lennox-Gastaut syndrome, which are both epilepsy syndromes. CBD has exhibited anti-epileptic actions and acts as an anticonvulsant as well as an antioxidant and neuroprotective. This means that even if an individual experiences a seizure, the compound offers protection against the electrical storm devastating the brain.
In his report, Gupta highlighted that some families had also turned to marijuana to help relieve the symptoms of autism, noting that the herb was an answer for many individuals. Research supports this, with findings from various studies showing that medical cannabis extracts appeared to manage the symptoms of kids suffering from autism.
Autism spectrum disorder, or autism in short, is a broad range of conditions characterized by repetitive behaviors and challenges with social skills. For instance, an Israeli clinical trial found that cannabis extracts improve the social responsiveness of children with autism and reduced their disruptive behavior.
Researchers advise that parents of children with autism wait for more data on the safety and effectiveness of cannabis in managing autism before they try treating their children with medical cannabis. This is because children treated with cannabis may sometimes suffer from disturbed sleep, sleepiness and reduced appetite.
Gupta also found that doctors in Israel had prescribed medical cannabis to more than 20,000 patients suffering from post-traumatic stress, epilepsy, cancer and degenerative ailments to help manage their symptoms. These findings make a strong case for the scientific community taking a closer look at what more the cannabis products manufactured by licensed companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) could offer in terms of possible benefits to the consumers.
NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
